Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02502019 · ClinicalTrials.gov registry record · Phase 1
HEMOBLAST Pilot Clinical Investigation
A Phase 1 study, sponsored by Biom'Up France SAS.
- Completed
- Registry status
- Phase 1
- Development phase
- 27
- Enrollment target
NCT02502019 is a Phase 1 study that has completed, run by Biom'Up France SAS. The registered enrollment target is 27 participants.
The verdict
NCT02502019, a Phase 1 study, has completed, sponsored by Biom'Up France SAS.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 27 participants
- Enrollment target
Study Summary
The primary objective of this pilot clinical investigation is to assess the reliability of the Surface Bleeding Severity Scale (SBSS) in a clinical setting. Secondary objectives of this clinical investigation are to collect initial data on the safety and efficacy of HEMOBLAST™ Bellows in abdominal and orthopedic lower extremity surgeries.
Interventions
- DEVICE HEMOBLAST Bellows
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 27 participants |
| Start Date | 2015-08 |
| Est. Completion | 2016-03 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02502019
The ClinicalTrials.gov registry entry for NCT02502019 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 27 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Biom'Up France SAS, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which HEMOBLAST Bellows is the first listed.
NCT02502019 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02502019 about?
NCT02502019 is a clinical study titled "HEMOBLAST Pilot Clinical Investigation". The primary objective of this pilot clinical investigation is to assess the reliability of the Surface Bleeding Severity Scale (SBSS) in a clinical setting. Secondary objectives of this clinical investigation are to collect initial data on the safety and efficacy of HEMOBLAST™ Bellows in abdominal a...
What is the current status of trial NCT02502019?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 27 participants. The study started on 2015-08. Estimated completion is 2016-03.
What interventions are being tested in trial NCT02502019?
The interventions under investigation include: HEMOBLAST Bellows (DEVICE).
Who is sponsoring clinical trial NCT02502019?
This trial is sponsored by Biom'Up France SAS, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.